ClinConnect ClinConnect Logo
Search / Trial NCT02861612

Nerve Transfers to Restore Hand Function in Spinal Cord Injury

Launched by OTTAWA HOSPITAL RESEARCH INSTITUTE · Aug 4, 2016

Trial Information

Current as of May 30, 2025

Withdrawn

Keywords

Peripheral Nerves Quadriplegia Nerve Transfer Surgical Procedures, Operative Hand Upper Extremity Quality Of Life

ClinConnect Summary

Cervical spinal cord injury is a life-altering injury that results in profound loss of upper limb function. Hand function is essential to basic activities of daily living and consequently has a significant impact on patients' quality of life. Tendon transfers and/or tenodesis have traditionally been used to restore hand function in spinal cord injuries - however, in recent years there is growing interest in the role of nerve transfers as a means of accomplishing this goal. Although preliminary results indicate nerve transfers may be well-suited for patients with spinal cord injury, their lo...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with a spinal cord injury AIS level C5 to C7. Those with motor complete injuries (AIS A or B) will be considered for surgical intervention if they are ≥ 5 months post injury. Motor incomplete patients (AIS C or D) will be considered if they are ≥ 1.5 years post injury.
  • Patients will require ≥ MRC 4 strength of the muscle supplied by the donor nerve (e.g. brachialis, supinator).
  • Finger flexor and extensor strength should be ≤ MRC 1 strength.
  • Muscles supplied by the donor nerve, will need to have no or minimal of evidence of lower motor neuron injury as dictated by evidence of fibrillations, positive sharp waves, or moderate or severely decreased recruitment on needle electromyography.
  • Those being evaluated for surgery outside nine-months post injury recipient muscles will be required to be free of lower motor neuron pathology.
  • Ability to comply and participate in rigorous post-surgical therapy regimen.
  • Exclusion Criteria:
  • Comorbidities precluding safe surgery including autonomic/hemodynamic instability, pulmonary instability, active infection, chronic pressure sores or untreated urinary tract infections as determined by physician.
  • Simultaneous tendon transfer or tenodesis surgery (which would preclude separation of the effect of nerve transfer alone).

About Ottawa Hospital Research Institute

The Ottawa Hospital Research Institute (OHRI) is a leading academic research institute dedicated to advancing health and healthcare through innovative research and evidence-based practices. Affiliated with The Ottawa Hospital and the University of Ottawa, OHRI fosters a collaborative environment that brings together clinicians, scientists, and trainees to conduct groundbreaking clinical trials and translational research. With a focus on improving patient outcomes, OHRI specializes in a wide range of fields, including cancer, cardiovascular health, and regenerative medicine. The institute is committed to ethical research practices and the dissemination of knowledge to enhance public health and inform healthcare policy.

Locations

Saint Louis, Missouri, United States

Ottawa, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Kirsty U Boyd, MD

Principal Investigator

The Ottawa Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials